North Bergen, New Jersey--(Newsfile Corp. - October 9, 2025) - Apollo Biowellness, Inc. (OTCID: KOAN) (the "Company"), is pleased to announce that it has completed the first step in the closing process with Revive Regenerative, Inc. The Company has secured the initial tranche of capital required in the amount of $500,000 as set forth in the merger agreement. In addition, the Company has finalized with GSS Capital to raise the additional $3,000,000 needed, with the terms agreed to by both sides. The Company uses the following handle on X at @ApolloBioKOAN to communicate with its shareholdersAbout Apollo Biowellness, Inc.Apollo Biowellness, Inc., and its subsidiary, Evolutionary Biologics, Inc., is engaged in the discovery, development and marketing of products designed to better mankind. Such statements involve risks and uncertainties that could negatively affect our business, operating results, financial condition and stock price.